Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.2850
-0.0134 (-4.49%)
At close: Nov 19, 2025, 4:00 PM EST
0.2851
+0.0001 (0.04%)
Pre-market: Nov 20, 2025, 5:32 AM EST
Applied Therapeutics Revenue
Applied Therapeutics had revenue of $1.00M in the quarter ending September 30, 2025, with 719.67% growth. This brings the company's revenue in the last twelve months to $1.00M, down -571.70% year-over-year. In the year 2024, Applied Therapeutics had annual revenue of $455.00K, down -95.45%.
Revenue (ttm)
$1.00M
Revenue Growth
-571.70%
P/S Ratio
41.32
Revenue / Employee
$28,571
Employees
35
Market Cap
41.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 455.00K | -9.54M | -95.45% |
| Dec 31, 2023 | 9.99M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
APLT News
- 6 days ago - Applied Therapeutics Tanks As FDA Path For Lead Rare-Disease Drug Turns Uncertain - Benzinga
- 6 days ago - Applied Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 22 days ago - Halper Sadeh LLC Encourages Applied Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 7 weeks ago - Applied Therapeutics Provides Update Following Meeting with FDA - GlobeNewsWire
- 3 months ago - Applied Therapeutics Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - Applied Therapeutics Announces Key Leadership Appointments - GlobeNewsWire
- 6 months ago - Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting - GlobeNewsWire
- 6 months ago - Applied Therapeutics Reports First Quarter 2025 Financial Results - GlobeNewsWire